These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25944898)

  • 1. Forkhead Box O6 (FoxO6) Depletion Attenuates Hepatic Gluconeogenesis and Protects against Fat-induced Glucose Disorder in Mice.
    Calabuig-Navarro V; Yamauchi J; Lee S; Zhang T; Liu YZ; Sadlek K; Coudriet GM; Piganelli JD; Jiang CL; Miller R; Lowe M; Harashima H; Dong HH
    J Biol Chem; 2015 Jun; 290(25):15581-15594. PubMed ID: 25944898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FoxO6 integrates insulin signaling with gluconeogenesis in the liver.
    Kim DH; Perdomo G; Zhang T; Slusher S; Lee S; Phillips BE; Fan Y; Giannoukakis N; Gramignoli R; Strom S; Ringquist S; Dong HH
    Diabetes; 2011 Nov; 60(11):2763-74. PubMed ID: 21940782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FoxO6 in glucose metabolism (FoxO6).
    Kim DH; Zhang T; Lee S; Dong HH
    J Diabetes; 2013 Sep; 5(3):233-40. PubMed ID: 23324123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FoxO6-mediated ApoC3 upregulation promotes hepatic steatosis and hyperlipidemia in aged rats fed a high-fat diet.
    Kim DH; Lee S; Noh SG; Lee J; Chung HY
    Aging (Albany NY); 2024 Mar; 16(5):4095-4115. PubMed ID: 38441531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone-induced Krüppel-like factor 9 expression promotes hepatic gluconeogenesis and hyperglycemia.
    Cui A; Fan H; Zhang Y; Zhang Y; Niu D; Liu S; Liu Q; Ma W; Shen Z; Shen L; Liu Y; Zhang H; Xue Y; Cui Y; Wang Q; Xiao X; Fang F; Yang J; Cui Q; Chang Y
    J Clin Invest; 2019 Apr; 129(6):2266-2278. PubMed ID: 31033478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoplasmic reticulum stress induces hepatic steatosis through interaction between PPARα and FoxO6 in vivo and in vitro.
    Kim DH
    J Mol Med (Berl); 2024 Oct; 102(10):1267-1284. PubMed ID: 39198274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of hepatic FoxO1/3/4 genes in mice significantly impacts on glucose metabolism through downregulation of gluconeogenesis and upregulation of glycolysis.
    Xiong X; Tao R; DePinho RA; Dong XC
    PLoS One; 2013; 8(8):e74340. PubMed ID: 24015318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered hepatic glucose homeostasis in AnxA6-KO mice fed a high-fat diet.
    Cairns R; Fischer AW; Blanco-Munoz P; Alvarez-Guaita A; Meneses-Salas E; Egert A; Buechler C; Hoy AJ; Heeren J; Enrich C; Rentero C; Grewal T
    PLoS One; 2018; 13(8):e0201310. PubMed ID: 30110341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c.
    Hagiwara A; Cornu M; Cybulski N; Polak P; Betz C; Trapani F; Terracciano L; Heim MH; Rüegg MA; Hall MN
    Cell Metab; 2012 May; 15(5):725-38. PubMed ID: 22521878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model.
    Amrutkar M; Cansby E; Chursa U; Nuñez-Durán E; Chanclón B; Ståhlman M; Fridén V; Mannerås-Holm L; Wickman A; Smith U; Bäckhed F; Borén J; Howell BW; Mahlapuu M
    Diabetes; 2015 Aug; 64(8):2791-804. PubMed ID: 25845663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective Effect of Vanillic Acid against Hyperinsulinemia, Hyperglycemia and Hyperlipidemia via Alleviating Hepatic Insulin Resistance and Inflammation in High-Fat Diet (HFD)-Fed Rats.
    Chang WC; Wu JS; Chen CW; Kuo PL; Chien HM; Wang YT; Shen SC
    Nutrients; 2015 Dec; 7(12):9946-59. PubMed ID: 26633482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FoxO integration of insulin signaling with glucose and lipid metabolism.
    Lee S; Dong HH
    J Endocrinol; 2017 May; 233(2):R67-R79. PubMed ID: 28213398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver.
    Kim DH; Zhang T; Lee S; Calabuig-Navarro V; Yamauchi J; Piccirillo A; Fan Y; Uppala R; Goetzman E; Dong HH
    Endocrinology; 2014 Apr; 155(4):1255-67. PubMed ID: 24437489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
    Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
    Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance.
    Nara N; Nakayama Y; Okamoto S; Tamura H; Kiyono M; Muraoka M; Tanaka K; Taya C; Shitara H; Ishii R; Yonekawa H; Minokoshi Y; Hara T
    J Biol Chem; 2007 Oct; 282(42):30794-803. PubMed ID: 17724031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EP
    Higuchi S; Fujikawa R; Nakatsuji M; Yasui M; Ikedo T; Nagata M; Mishima K; Irie K; Matsumoto M; Yokode M; Minami M
    Am J Physiol Endocrinol Metab; 2019 Mar; 316(3):E410-E417. PubMed ID: 30562059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways.
    Vatner DF; Weismann D; Beddow SA; Kumashiro N; Erion DM; Liao XH; Grover GJ; Webb P; Phillips KJ; Weiss RE; Bogan JS; Baxter J; Shulman GI; Samuel VT
    Am J Physiol Endocrinol Metab; 2013 Jul; 305(1):E89-100. PubMed ID: 23651850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catestatin Inhibits Obesity-Induced Macrophage Infiltration and Inflammation in the Liver and Suppresses Hepatic Glucose Production, Leading to Improved Insulin Sensitivity.
    Ying W; Mahata S; Bandyopadhyay GK; Zhou Z; Wollam J; Vu J; Mayoral R; Chi NW; Webster NJG; Corti A; Mahata SK
    Diabetes; 2018 May; 67(5):841-848. PubMed ID: 29432123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TOX3 deficiency mitigates hyperglycemia by suppressing hepatic gluconeogenesis through FoxO1.
    Liu C; Zheng Y; Hu S; Liang X; Li Y; Yu Z; Liu Y; Bian Y; Man Y; Zhao S; Liu X; Liu H; Huang T; Ma J; Chen ZJ; Zhao H; Zhang Y
    Metabolism; 2024 Mar; 152():155766. PubMed ID: 38145825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hepatic FOXQ1 transcription factor regulates glucose metabolism in mice.
    Cui Y; Qiao A; Jiao T; Zhang H; Xue Y; Zou Y; Cui A; Fang F; Chang Y
    Diabetologia; 2016 Oct; 59(10):2229-39. PubMed ID: 27421728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.